A PROCESS FOR THE PRODUCTION OF ENZYME FIXED RESIN MATERIAL AND A METHOD FOR THE REGENERATION THEREOF

Abstract: An immobilised enzyme composition is disclosed com­ prising a macrororeticular styrene-divinylbenzene basic anion exchange resin having an enzyme adsorbed and revers­ ibly cross-linked therein by reaction with a polyvalent aldehyde. Regeneration is effected by treatment with an acid/salt solution thereby to rupture the cross-links and desorb the enzyme, followed by the adsorption and cross-­ linking of fresh enzyme onto the desorbed resin.

Description: ENZYME-FIXED RESIN MATERIAL, A PROCESS FOR THE PRODUCTION ArJD A METHOD FOR THE REGENERATION THEREOF This invention relates to an enzyme-fixed resin material, a process for production of this material and a method for regeneration thereof. Heretofore, in producing a fixed enzyme by an adsorption method, an anion or cation exchange resin of a macro-porous type or a macro-reticular structure has been employed, but such a resin has a number of problems. For example, in a process employing Duolite A7 which is a polyphenol type weakly basic anion exchange resin (Japanese Published Unexamined Patent Application 80160/1974), elution is difficult and, hence, regeneration is difficult because adsorption is strong. On this ground, it is proposed to weaken the adsorption due to the hydrophobic properties by further introducing hydrophilic groups (Japanese Published Unexamined Patent Application 85890/1978), but this proposal is not adequate. On the other hand, in a method employing Amberlite IRA-904 which is a styrene-divinylbenzene type weakly basic anion exchange resin (Japanese Published Unexamined Patent Application 53584/1975), the enzyme is generally loosely adsorbed and gradually comes off during use, and also the preferential adsorption of polysaccarides occurs (Japanese Published Unexamined Patent Application 147992/1979). In a continuous method which employs a fixed enzyme, contamination with infectious microbes in a reactor often becomes a problem and, as countermeasures therefor, conditions of a high substrate concentration and medium to high temperatures are employed. However, the countermeasures in turn often cause the deterioration of the resin (for example, obstructfion of the contact of a strate with the enzyme due to polysaccharides irreversibly adsorbed, etc.). Under the above circumstances, it has been found in accordance with this invention that it is possible to obtain an enzyme-fixed resin material which can stand continuous use at medium to high temperature and can be regenerated and reused by selecting a styrene-divinylbenzene type basic anion exchange resin which is hard to deteriorate and on which reversible adsorption occurs in general and by overcoming the drawback of weak adsorption by crosslinking with a polyvalent aldehyde. The polyvalent aldehyde crosslinkes enzymes by chemically combining with functional groups, especially amino groups in the enzymes. In this aspect, it is necessary that any functional group containing nitrogen does not contain active hydrogen. The present invention is described in more detail hereinafter. As the styrene-divinylbenzene type basic anion exchange resin having a macro-reticular structure and wherein any ion exchange group containing nitrogen does not have active hydrogen, those having the mean macropore -o radius of 100 - 2000 A (0.01 to 0.2liy) especially 200 - 1000 A (0.02 to 0.1pom) and the macropore volume of 0.1 ml/g or more, especially 0.2 - 1.0 ml/g, for example, Imac A20S, A2OR [tradenames by Duolite International Co. (France)), Lewatit MPSOOA [tradename by Bayer Co. (West Germany)], Duolite A378, A369, A368 [tradenames by Diamond Shamrock Co. (U.S.A.)], and Diaion HPA75, HPA25 [tradenames by mitsubishi Chemical Industries Co. Ltd. (3apan)) can be preferably employed. Polyvalent aldehydes to be used are not specifically limited, but preferably include saturated aliphatic dialdehydes having 2 - 10 carbon atoms such as glyoxal, malonaldehyde, succinaldehyde, glutaraldehyde and adipoaldehyde. Enzymes to be uscd¯in the present invention are not specifically limited, and include oxidoreductase, transferase, hydrogenase, lease, isomerase, ligase, and the like. In particular, glucose isomerase, glucoamylase, fumarase, aspartase, lipase, invertase, protease, unease, amino acid oxidase, etc., are especially suitable The production of the enzyme-fixed resin material of the present invention is described hereinafter. The present enzyme-fixed resin material may be obtained by bringing a styrene-divinylbenzene type basic anion exchange resin which has a macro-reticular structure and wherein any nitrogen-containing ion exchange group does not have active hydrogen into contact with a solution containing an enzyme to make the enzyme adsorbed on the resin, then bringing the resin into contact with a solution of a substrate for said enzyme and further bringing the resin into contact with a polyvalent aldehyde solution. As the solution containing the enzyme, there may be employed a microbial cell fracture liquor or its filtrate, a solution of a crude enzyme in water or a buffer solution, the crude enzyme being obtained by precipitation with ammonium sulfate or with a solvent from the filtrate, a solution obtained by further dialyzing the solution, a purified enzyme solution, etc. Suitable range of concentration of the enzyme solution is 0.01-200 mg/l as protein. The amount of the resin to be used may be prescribed as the amount of the enzyme to be adsorbed, and is generally suitably in the range of 0.1-100 mg-protein/ mi-resin. The adsorption of the enzyme is conducted generally in a batchwise operation with stirring at 0 - 400C for 30 minutes to 72 hours. Alternatively, the adsorption may be conducted by passing an enzyme solution through a column packed with a resin. The pH is maintained within a pH region where the enzyme is stable, generally at 4 - 10, and the pH adjustment is preferably done with a buffer solution. Thereafter, with or without solid-liquid separation, the resin is brought into contact with a solution of a substrate for the enzyme. This treatment is for preventing that the active centers are affected in the subsequent treatment with the polyvalent aldehyde, by temporarily combining the active centers with the substrate. The contact may be conducted batchwise or in a column similarly as the adsorption of the enzyme. As the substrate, substrates for the respective enzymes may be employed and, for example, fumaric acid, malic acid, sodium, ammonium and potassium salts thereof, etc., for fumarase; glucose, fructose, etc., for glucose isomerase; and soluble starch, maltose, glucose, maltotriose, etc., for glucoamylase are employed. As the substrate solution, an aqueous solution, a buffer solution, etc., of the substrate may be employed. The concentration of the substrate at the contact is 0.1 mM - 1.0 M, and where the substrate is an electrolyte, it is preferred that the concentration is 0.2 M or less in order to prevent the desorption of the enzyme due to the electrolyte. The amount of the substrate to be used is suitably in the range of about 10-1,000 times the molar amount of polyvalent aldehyde to be used, considering that the substrate protects the active center in competition with the polyvalent aldehyde. The treating temperature, pH, etc., may be similar to those of the adsorption of the enzyme, and the time may vary from about 10 minutes to 10 hours depending on the amounts of the substrate and the polyvalent aldehyde; generally the time is 30 - 60 minutes. Thereafter, the mixture is brought into contact with the polyvalent aldehyde solution without solid-liquid separation. The method for contact may be similar to that in the substrate treatment. The polyvalent aldehyde solution is generally an aqueous solution of a polyvalent aldehyde or, where sparingly soluble in water, methanol, ethanol, or the like solution, and the concentration at contact is suitably 1 - 100 mM. The amount of the polyvalent aldehyde used is in the range of 0.001 mI to 1 mM per mg of the protein. The treatment with the polyvalent aldehyde is generally conducted at 0 - 400C for one minute to 48 hours. Further, it is preferred to keep the pH constant in the stable pH range of the enzyme by using a buffer solution, etc. After the treatment with the polyvalent aldehyde, the resin is washed with a buffer solution, water, methanol, ethanol, etc., to remove the unreacted polyvalent aldehyde, the unreacted protein, etc., whereby an enzymefixed resin material is obtained. The present enzyme-fixed resin material excellently manifest activity and causes substantially no side reactions. Further, the present resin material is improved in heat resistance and, for example, the activity can be maintained even in continuous use at 40 - 700C for a long period, e.g. for at least 3 - 10 months in case of the fumarase-fixed resin material. Furthermore, the resin can be regenerated by bringing the enzyme-fixed resin material deteriorated after use for a certain period into contact with an aqueous mineral acid solution containing 0.2-5 M salt to cut the crosslinks by the polyvalent aldehyde and desorb the enzyme. As the salt, a strong alkali salt or weak alkali salt of a strong acid, especially a strong alkali salt, is preferred. For example, alkali metal salts (e.g., sodium chloride, sodium sulfate, etc.), alkaline earth metal salts (e.g., calcium chloride, etc.), and ammonium salts (e.g. ammonium chloride, etc.) of sulfuric acid, hydrochloric acid, phosphoric acid, etc., are employed. As the mineral acid, sulfuric acid, hydrochloric acid, phosphoric acid, etc., are employed. As the mode for the contact, a batchwise mode with stirring, passing a liquor for regeneration through a resin material packed in a column, etc., are applied. The operation at the contact is suitably conducted at a mineral acid concentration of 0.5- 6 N and 40 - 950C. By subjecting the regenerated resin to an enzyme fixing operation similar to the above, an enzyme-fixed resin material may be obtained, and the activity and characteristics of the material are maintained at nearly the same level as in the case where a new resin is employed. Further, similar characteristics may be maintained also after twice or three times of regeneration and reuse. As regards the regeneration and reuse of the carrier, there is a method by electrolytic salt aqueous solution treatment and acid treatment (Japanese Published Unexamined Patent Application 70871/1976), but the regeneration by cutting the crosslinkes requires treatment with an aqueous mineral acid solution containing a salt, and thus the regenerating method of the present invention is fundamentally different from the method described in the above laid-open patent application. The present invention is described in more detail below referring to the following examples. Example 1 At first, 300 ml of a medium containing 10% glucose, 0.5% potassium dihydrogenphosphate, 0.68 urea, 0.05% magnesium sulfate (heptahydrate), 2% peptone, 0.05% meat extract and 50 y/l biotin is charged into a 2,000 ml Erlenmeyer flask, and a fumarase-producing microorganism, Corynebacterium glutamicum ATCC 21513 is inoculated and cultured, with shaking, at a culture temperature of 30"C for 48 hours. The microbial cells are collected from the culture liquor, washed, and freeze-dried to obtain 9 g of the microbial cells. The microbial cells are dispersed in a 0.1 M phosphate buffer (pHt6,0) at a concentration of 50 g/l, and subjected to ultrasonic treatment. As the carriers, there are used Imac A2OS (Duolite International Co., France) as the carrier of the present invention and Duolite A6 (Diamond Shamrock Co., U.S.A.) as a control. Each carrier is washed thoroughly with deio- nized water and, thereafter, buffered with a 0.1 M phosphate buffer (pH 6.0). Thereafter, the crude enzyme suspension prepared above is brought into contact with the resin at a proportion of 200 U (as the activity value) per ml of the resin at room temperature for 16 hours. The amount of the protein adsorbed is 90% or more in either case. Thereafter, an equal amount to that of the resin of a 0.1 M aqueous sodium fumarate solution is added thereto as a stabilizer for the enzyme. The supernatant is discarded, and then an equal amount to that of the resin of a 0.2% aqueous glutaraldehyde solution is added to the resin to conduct the reaction at room temperature for 30 minutes. Each resin is thoroughly washed to obtain fixed enzyme carriers A (Imac A20S) and B (Duolite A6), respectively. Each fixed enzyme is filled into a 10 ml-jacketed column, and a 1 M aqueous sodium fumerate solution is passed through the column at 500C at a space velocity of So=0.3 (feed vol./carrier-vol..hr). Conversions to malic acid of about 80% with the carrier A and about 78% with the carrier B are obtained over 20 days, which exhibits that a continuous production is possible. Example 2 When operations are continued with the carriers of Example 1 for another month, conversions are reduced to about 78% with the carrier A and about 75% with the carrier B, but there is no contamination due to infectious microbes. Further, the resin is pulled out from the column, 0.5 N sulfuric acid containing 0.5 M sodium chloride is added to the resin, and the mixture is heated at 700C and maintained at the same temperature for 2 hours. The resin is washed with deionized water, and an enzyme is again fixed thereto in the same manner as in Example 1. Namely, the crude enzyme suspension is prepared in the same manner as in Example 1, and the enzyme suspension is brought into contact with the resin at a proportion of 200 U per ml of the resin to adsorb the enzyme. The amounts of the protein adsorbed are 90% with the carrier A and 40% with the carrier B. Similarly, a sodium fumarate solution is added thereto, and crosslinking is conducted using glutaraldehyde in the same manner as in Example 1 to fix the enzyme. The fixed enzyme carriers A and B are thoroughly washed and filled into 10 ml-columns, respectively, and a 1 M aqueous sodium fumarate solution is passed through each column at So=0.3. Conversion to malic acid in the effluent can be maintained at 80% for 20 days with the carrier A; whereas it rapidly drops to 25% on the first day, to 15% on the 10th day, and to 11% on the 20th day with the carrier B. Further, regeneration and reuse of the fixed enzyme carrier A are repeated in the same manner as above, and as the result, conversion to malic acid in the effluent can be maintained at 80% for 20 days both in the second and third reuses. Example 3 At first, 25 g of wet microbial cells of Streptomyces phaeochromogenes IFO 3105 are autodigested in a 0.02 M phosphate buffer (pH 8), and thereafter the mixture is filtered to obtain a glucose isomerase enzyme solution. Duolite A378 (Diamond Shamrock Co., U.S.A.) buffered to pH 8 is suspended in the enzyme solution, and the suspension is adjusted to pH 8.2, and thereafter mildly stirred at room temperature for about 16 hours. Thereafter, the supernatant is discarded, and 50 ml of a 1% aqueous glucose solution is added to the resin. The mixture is mildly stirred for 10 minutes, and then the supernatant is discarded. Then, 50 ml of a 0.2% aqueous glutaraldehyde solution is added to the resin, and the mixture is mildly stirred at room temperature for 30 minutes to conduct crosslinking. The resin is charged into a column and thoroughly washed with water. A 0.5 M glucose solution containing 0.05 M MgSO4 and 5x10 4 M Cod2 is passed through the insoluble enzyme column at a rate of 500 ml per hour (SV=10) at 600C. The fructose in the effluent is 30 mg/ml by the cystein-carbazole method. Where passed at So=4, the fructose is 46 mg/ml and the glucose is 44 mg/ml by the glucose oxidase method, and thus a degree of isomerization of 51% is obtained. Further, when the sugar solution is continuously passed through the column at SV=4 for 20 days, the degree of isomerization is 49% on the 20th day. Then, the resin is pulled out from the column and thoroughly washed with water, and 0.5 N sulfuric acid containing 0.5 M sodium chloride is added thereto. The mixture is heated at 700C for 2 hours. The resin is washed, and fixing is ccnducted in the same manner as in the first fixing operation. When the same sugar solution as above is passed through the ref fixed carrier at SV = 10, the fructose in the effluent is 31 mg/ml, from which it is apparent that the ref fixed resin exhibits the same degree of activity as the new resin. Example 4 Glucoamylase (produced by Nagase Sangyo Co., Ltd.) is dissolved in a 0.1 M acetate buffer of pH 4.5 to prepare a solution containing 14 mg of the enzyme as protein per ml. Then, 10 ml of the solution is added to 5 ml of HPA75 resin (produced by Mitsubishi Chemical Industries Co., Ltd.), and the mixture is shaken in a thermostat of 370C for 16 hours, whereby 22 mg of the protein is adsorbed per ml of the resin. Further, the resin is washed, the supernatant is discarded, 5 ml of a 1% aqueous soluble starch solution is added to the resin, and the mixture is mildly stirred. Then, the supernatant is discarded, 5 ml of a 0.2% aqueous glutaraldehyde solution is added to the resin, and the mixture is mildly stirred at room temperature for 30 minutes to effect crosslinking. The resin is transferred to a column, thoroughly washed with water, and a 10% aqueous soluble starch solution is passed through the insoluble enzyme column at SV=l.0 at 50 C. The glucose concentration in the effluent is 85 g/l on the third day, and 83 g/l on the 10th day. Further, when passed through the column for 50 days, the glucose concentration is somewhat reduced to 80 g/l, but contamination with infectious microbes is not remarkably observed. Further, the resin is pulled out and washed with water, and then 0.5 N sulfuric acid containing 0.5 M sodium chloride is added to the resin. The mixture is heated at 700C for 2 hours. The resin is washed, and fixing is conducted in the same manner as in a new resin. The obtained resin is transferred to a column, and a 10% aqueous soluble starch solution is passed through the insoluble enzyme column at So= 1.0 at 500C. The glucose concentration in the effluent is 85 g/l on the third day, and 83 g/l on the 10th day. As a control, the above-described fixing operation is repeated using a Duolite A7 resin. The obtained enzyme-fixed resin is filled in a column, and a 10% aqueous soluble starch solution is passed at SV=l.0 at 500C. The glucose concentration in the effluent is 80 g/l on the third day, and 78 g/l on the 10th day. Further, on the 20th day, it is reduced down to 40 g/l. Thereafter, regeneration and fixing are effected similarly as in the above-described example. The glucose concentration in the effluent in the case where the ref fixed carrier is used cannot give results satisfactory for reuse; i.e., 30 g/l on the third day, and 25 g/l on the 10th day. Further, an enzyme-fixed Duolite A7 resin is prepared in the same manner as above, and a 10% aqueous soluble starch solution is passed at So=1.0 at 400C. In this case, contamination with infectious microbes gra;iuaIly proceeds, and the glucose concentration is reduced to 75 g/l on the third day, and to 60 g/l on the 10th day. Similar results are obtained when Imac A20SU resin is used in place of Duolite A7 resin in the same procedure under the same conditions as above. Further, comparison with a fixing method employing a Duolite A7 resin, but not employing glutaraldehydeismade hereinafter. Namely, 10 ml of the Duolite A7 resin is mixed with 20 ml of a glucoamylase solution of a concentration of 14 mg/ml as a protein prepared using a 0.1 M acetate buffer (pH 4.5). The mixture is shaken at 370C for 16 hours to effect fixing of the enzyme, whereby 23 mg of the protein is adsorbed. Each 5 ml of the resin is filled in two columns and washed, and a 10% aqueous soluble starch solution is passed through each insoluble enzyme column at SV = 1.0. One column is maintained at a temperature of 500C (Experiment A), and the other at 400C (Experiment B). In case of Experiment A, the glucose concentration in the effluent is 78 g/l on the third day, and 65 g/l on the 10th day, which reveals large drop of the enzyme activity. In case of Experiment B, the glucose concentration in the effluent is reduced to 73 g/l on the third day and to 58 g/l on the 10th day, and also contamination with infectious microbes is observed. Regeneration and fixing are conducted using both carriers in Experiments A and B. The regenerating conditions are a method of heating the used resin in 0.5 N sulfuric acid containing 0.5 M sodium chloride at 700C (Experiments A-l and B-1) and a method of heating the used resin in 4 N sodium hydroxide at 600C (Experiments A-2 and B-2). The regenerated resins are ref fixed in the same manner as in the first fixing. The amounts of the protein adsorbed are 10 mg in A-l, 10 mg in B-l, 15 mg in A-2 and 13 mg in B-2, and thus the adsorption ability is reduced as compared in the first time. When the resins are filled into columns and a 10% aqueous soluble starch solution is passed through each column at So " 1.0 at 400C, the glucose concentration in the effluent are merely 20 mg/ml in A-l, 18 mg/ml in B-l, 25 mg/ml in A-2, and 20 mg/ml in B-2 on the third day, respectively. Example 5 The same procedure as in Example 1, is repeated except that Lewatit MP 500 A is used in place of Imac A 20 S and almost the same result as therein is obtained.

Claims: CLAIMS 1. An immobilised enzyme composition comprising a macroreticular styrene-divinylbenzene basic anion exchange resin having adsorbed therein an enzyme, characterised in that the adsorbed enzyme molecules are cross-linked with one another by reaction of the enzyme in situ with a polyvalent aldehyde. 2. An immobilised enzyme composition according to claim 1, wherein said resin has a mean macropore radius of 100 - 2000at (0.01 to 0.2 Dm) and a macropore volume of 0.1 ml/g or more. 3. An immobilised enzyme composition according to claim 2, wherein said resin has a mean macropore radius of 200 - 1000A (0.02 to 0.1pom) a macropore volume of 0.2 - 1.0 ml/g. 4. An immobilised enzyme co-position according to claim 1, 2 or 3 wherein said resin is Imac A20S, A20R, Duolite A378, A369, A36B, Lewatit MPSODA, Diaion HPA75 or HPA25. 5. An immobilised enzyme composition according to any one of claims 1 - 4 wherein enzyme is cross-linked by reaction with a saturated aliphatic dialdehyde having 2 - 10 carbon atoms. 6. An immobilised enzyme composition according to any one of claims 1 - 5, wherein the enzyme is oxidoreductase, transferase, hydrogenase, lyase, isomerase or ligase. 7. An immobilised enzyme composition according to any one of claims 1 - 5 wherein the enzyme is glucose isomerase, glucoamylase, fumarase, aspartase, lipase, invertase, protease, urease or amino acid oxidase. 8. A method of immobilising an enzyme, which comprises adsorbing the enzyme on a macroreticular styrenedivinylbenzene basic anion exchange resin, character lied in that after adsorption the enzyme is crosslinked in situ by reaction with a polyvalent aldehyda. 9. A method according to claim 8, characterised in that, following adsorption onto the resin and before cross-linking with said aldehyde, the adsorbed enzyme is contacted with a substrate for the enzyme thereby blocking reactive sites on the adsorbed enzyme prior to croas-linkin with the aldehyde. 10. A method according to claim e or 9. @@ applied toto the manufacture of an immobilised enzyme composition as claimed in any one of claims 2 11. A method of regeneratlng an immobilised enzyme composition1 being a composition as claimed in any one of claims 1 -7, which comprises treating the immobilised enzyme composition with an aqueous mineral acid solution containing en alkaline salt of mineral ecid at e concentration of from 0.2 to 5 M, thereby rupturing the bonds cross-linking the enzyme and desorbing the enzyme from the resin, and adsorbing fresh enzyme into the resin by the method claimed in claim 8 9 or 10. 12. A method according to claim 11, wherein the aqueous acid solution used to rupture the cross-linking bonds and desorb the enzyme comprises a mineral acid at a concentration of 0.5 - 6 N. 13. A method according to claim 11 or 12, wherein the alkaline salt is an alkali metal, alkaline earth metal or ammonium salt of sulfuric acid, hydrochloric acid or phosphoric acid, and the mineral acid is sulfuric acid, hydrochloric acid or phosphoric acid.

Inventors: AZUMA, MASAKI, NAGASHIMA, MINORU, NOGUCHI, SADAO
Applicants: KYOWA HAKKO KOGYO CO., LTD.
Application year: 1984
Main classification: C12N11
IPC codes: C12N11